Handelsavisen
prelaunch
Companies Health Care POM.HNO
PO
POM.HNO Diversified Pharmaceuticals

Pomina Steel Corp

$4 300,00
Open in Charts → Attach watcher ⌖
USD
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
P/E
EV / Rev
Div yield
0,00 %
Op margin
-43,1 %
ROE
-19,3 %
Net margin
-47,7 %
Debt / equity
5,36
Beta
52w range
Volume
Day range
Prev close
$0,86
Open
Next earnings
2026-07-28
Ex-dividend
TR 1Y
About

Pomina Steel Corp exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 5.36, significantly above the industry median. The company's liquidity position is weak, as evidenced by a current ratio of 0.31, indicating that it holds insufficient current assets to cover its short-term liabilities. Despite a positive operating cash flow of VND 67.33 billion, the company's free cash flow is negative at VND -182.95 billion, reflecting high capital expenditures or debt servicing costs. Profitability metrics are deeply negative, with a return on equity of -19.32% and a return on assets of -2.23%. These figures suggest that the company is not generating returns that exceed its cost of capital, and its operating performance is below the industry median for profitability. The company's net income is negative at VND -224.90 billion, and its operating income is also negative at VND -202.97 billion, indicating a significant decline in operational efficiency or pricing power. The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or regula

Business. Pomina Steel Corp (POM.HNO) is a basic materials company operating in the iron and steel industry, primarily engaged in mining activities. The firm generates revenue through the sale of products and is tracked under the POM.HNO ticker. Specific details regarding operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

Classification99 %
SectorHealth Care
Industry groupDiversified Pharmaceuticals
Generated · model-assisted
Sell-side consensus
consensus pending
— buy— hold— sell
Avg 12m price target
Upcoming events
  • EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
See all catalysts →

At a glance

Score
not yet scored
Valuation
valuation pending
Analysts
not yet wired
Ownership
not yet wired
Profitability
-19,3 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning POM.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,7 %+1,5 %
    Communication Services+2,2 %−5,5 %+1,5 %
    Energy+0,9 %+5,2 %+0,1 %
    Health Care · THIS SECTOR+0,7 %−0,8 %−0,1 %
    Information Technology+0,2 %+8,1 %−0,5 %
    Consumer Discretionary+0,2 %+8,7 %−0,6 %
    Financials−0,3 %−2,8 %−1,0 %
    Consumer Staples−0,6 %+2,2 %−1,3 %
    Real Estate−0,7 %+10,9 %−1,5 %
    Industrials−1,1 %−0,3 %−1,9 %
    Utilities−1,9 %+28,2 %−2,6 %

    Developing storylines

    No tracked sagas currently linked to POM.HNO. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-07-26 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Company
    • EarningsQ2 2026 earnings (expected)2026-07-28 · estimated
    • Macro
    • Rate decisionFederal Reserve rate decision (press conf.)2026-07-29 · US
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    Pomina Steel Corp (POM.HNO) is a basic materials company operating in the iron and steel industry, primarily engaged in mining activities. The firm generates revenue through the sale of products and is tracked under the POM.HNO ticker. Specific details regarding operating segments, headquarters location, and geographic revenue mix are not available in the provided data.

    Classification99 %
    SectorHealth Care
    Industry groupDiversified Pharmaceuticals
    AI synthesis
    GENERATED

    Pomina Steel Corp exhibits a highly leveraged capital structure, with a debt-to-equity ratio of 5.36, significantly above the industry median. The company's liquidity position is weak, as evidenced by a current ratio of 0.31, indicating that it holds insufficient current assets to cover its short-term liabilities. Despite a positive operating cash flow of VND 67.33 billion, the company's free cash flow is negative at VND -182.95 billion, reflecting high capital expenditures or debt servicing costs.

    Profitability metrics are deeply negative, with a return on equity of -19.32% and a return on assets of -2.23%. These figures suggest that the company is not generating returns that exceed its cost of capital, and its operating performance is below the industry median for profitability. The company's net income is negative at VND -224.90 billion, and its operating income is also negative at VND -202.97 billion, indicating a significant decline in operational efficiency or pricing power.

    The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic downturns or regulatory changes. The absence of segment or geographic breakdown in the financial data suggests that Pomina Steel Corp may be vulnerable to localized disruptions in its operations.

    Looking ahead, the company's growth trajectory is uncertain. With a negative net income and declining profitability, the outlook for revenue and earnings is bearish. The company's operating cash flow is insufficient to cover capital expenditures, suggesting that it may need to rely on external financing to fund operations or expansion. The absence of a clear growth strategy or diversification plan raises concerns about long-term sustainability.

    Risk factors include high leverage, weak liquidity, and negative profitability. The company's debt-to-equity ratio of 5.36 is a red flag, and the negative free cash flow indicates that it is not generating sufficient internal cash to service its debt. The risk of dilution is currently low, but the company's capital structure leaves it vulnerable to further equity issuance if debt financing becomes constrained.

    Recent filings and transcripts do not provide additional insight into the company's strategic direction or operational performance. The absence of recent disclosures on capital allocation, cost management, or market expansion efforts suggests that the company may be in a reactive rather than proactive mode. Investors should monitor the company's ability to improve its operating margins and reduce leverage in the coming quarters.

    Key takeaways
    • Pomina Steel Corp is highly leveraged, with a debt-to-equity ratio of 5.36, significantly above the industry median.
    • The company is unprofitable, with a return on equity of -19.32% and a return on assets of -2.23%.
    • Liquidity is weak, with a current ratio of 0.31 and negative free cash flow of VND -182.95 billion.
    • The company lacks geographic and segment diversification, increasing its exposure to localized risks.
    • Growth prospects are uncertain, with no clear strategy for improving profitability or reducing leverage.
    • The risk of dilution is currently low, but the company's capital structure leaves it vulnerable to further equity issuance.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Net income improved by 15.4% year-over-year to a loss of 837 billion VND, indicating a narrowing of operational deficits.

    Operating income rose 11.2% year-over-year, suggesting a modest stabilization in core business profitability trends.

    Gross profit turned positive at 107 billion VND, marking a reversal from negative gross margins in prior periods.

    BEAR CASE · 3

    The company carries a high credit risk flag, signaling significant concerns regarding its ability to meet debt obligations.

    Debt-to-equity ratio stands at 5.36, placing the company in the bottom quartile compared to 452 peer firms.

    Current ratio of 0.48 indicates severe liquidity constraints, as current assets cover less than half of current liabilities.

    In focus — financials by report

    Annual
    ANNUALFiled 2015-02-16
    FY 2015 · Full-year highlights

    Revenue VND 13.02T, −7,0% YoY; Operating income −594,5% YoY.

    RevenueVND 13.02T−7,0 % YoY
    Operating income-VND 1.08T−594,5 % YoY
    Net income-VND 1.08T−691,8 % YoY
    Free cash flow-VND 893.24B−78,0 % YoY
    EPS
    Operating cash flowVND 2.10T+556,2 % YoY
    Financials
    Income statement
    RevenueVND 13.02T
    Gross profit-VND 424.07B
    Operating income-VND 1.08T
    Net income-VND 1.08T
    Margins
    Gross margin-3.3%
    Operating margin-8.3%
    Net margin-8.3%
    FCF margin-6.9%
    Balance sheet
    Total assetsVND 11.03T
    Total liabilitiesVND 8.42T
    Total equityVND 2.61T
    Cash & equivalentsVND 1.00B
    Long-term debtVND 6.22T
    Cash flow
    Operating cash flowVND 2.10T
    CapEx-VND 47.10B
    Free cash flow-VND 893.24B
    SBC
    P&L flow · revenue → net income
    Revenue VND 471.44BOperating costs VND 674.41BFinance VND 145.34BNet income VND 224.90B
    Highlights
    • Revenue VND 13.02T, −7,0% YoY
    • Operating income −594,5% YoY
    • Net income −691,8% YoY
    • Free cash flow −78,0% YoY
    • Net margin -8.3%

    Valuation FY

    Market price
    $4 300,00
    Market cap
    Enterprise value
    P/E
    Non-GAAP P/E
    EV / Revenue
    EV / Op income
    EV / OCF
    P / B
    P / Tangible book
    Tangible book
    $1.16T
    Net cash
    -$6.23T
    Current ratio
    0.3
    Debt / equity
    5.4
    ROA
    -2.2%
    ROE
    -19.3%
    Cash conversion
    -30.0%
    CapEx / revenue
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    INDUSTRYSEGMENTCOMPANYHealthcareIndustryDiversified Pharmaceuticals1 042,4B node revenueMCK 38,7%COR 30,8%CAH 21,4%DB 3,4%REGN 1,4%BIIB 0,9%ZTS 0,9%GRFS 0,8%Other 1,7%
    Source: company disclosures · own-taxonomy revenue-covered set · attribution: collision-suspect (indicative)POM 0,0% · rank #22 of 40

    Business relationships

    Business relationships1 disclosed relationship · 1 type · extracted from filings & disclosures
    Partners1

    Supply chain

    Vendors → POM ↔ Partners → Customers · click any node to drill
    VENDORSPARTNERSCUSTOMERSPOMPOMPomina Steel Corp1 entityFocus Media InformatioUnclassifiedCN
    1 mention in 10-K0 from corporate websites0 from news dispatches
    Updated 2026-06-24

    Peer comparison

    Peer comparison8 peers · vs POM · multiples and returns
    MC
    MCK
    Mckesson Corp
    $824,49
    102,3B USD
    P/E
    21,2x
    vs self
    Div yield
    0,4 %
    vs self
    ROE
    -219,2 %
    vs self
    CO
    COR
    Cencora Inc
    $305,06
    59,2B USD
    P/E
    35,5x
    vs self
    Div yield
    0,7 %
    vs self
    ROE
    103,1 %
    vs self
    CA
    CAH
    Cardinal Health Inc
    $225,98
    54,7B USD
    P/E
    36,7x
    vs self
    Div yield
    0,9 %
    vs self
    ROE
    -55,9 %
    vs self
    DB
    DB
    DB.V
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    RE
    REGN
    REGENERON PHARMACEUTICALS, INC.
    $651,91
    70,2B USD
    P/E
    15,6x
    vs self
    Div yield
    vs self
    ROE
    14,3 %
    vs self
    BI
    BIIB
    BIOGEN INC.
    $201,80
    29,6B USD
    P/E
    21,3x
    vs self
    Div yield
    vs self
    ROE
    7,5 %
    vs self
    ZT
    ZTS
    Zoetis Inc
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self
    GR
    GRFS
    Grifols SA
    $8,05
    P/E
    vs self
    Div yield
    vs self
    ROE
    vs self

    Market position

    Stress test

    — missing data

    Predictor forecast

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    — missing data

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskMedium
    Filing-based flags
    • Net cash is negative after subtracting total debt.

    Benchmarks vs cohort

    Op Margin-43,0 %Below median
    Net Margin-47,7 %Below median
    ROE-19,3 %Below median
    D/E5,36Bottom quartile
    Cash Conv-0,30Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Net Cash
      cash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
    • Return On Equity
      net_income / total_equity
    • Debt To Equity
      (short_term_debt + long_term_debt) / total_equity
    • Cash Conversion Ratio
      operating_cash_flow / net_income
    • Return On Assets
      net_income / total_assets
    Source documents
    • Pomina Steel Corp Market data — financials · 2026-05-29

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    POM.HNOCanonical
    — · USD

    Intel & risk

    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskMedium
    Net cash is negative after subtracting total debt.
    Relationship graph
    POM002027.SDiversified Ph
    This companySectorPartners

    Evidence & claims

    From filings & derived data
    • Gross margin (FY 2025-12-31): 13.1%Derived (calculated)
    • Cash & equivalents (YoY) (2025-12-31 vs 2024-12-31): 25.2%Derived (calculated)
    • Debt-to-equity (FY 2025-12-31): -1.30xDerived (calculated)
    • Current ratio (FY 2025-12-31): 0.48xDerived (calculated)
    • Current liabilities (annual): USD 31.2MSEC XBRL filing
    • Shareholders' equity (annual): USD -64.92MSEC XBRL filing
    • EPS (basic) (annual): USD-PER-SHARES -3SEC XBRL filing
    • EPS (diluted) (annual): USD-PER-SHARES -3SEC XBRL filing
    • Total assets (annual): USD 15.38MSEC XBRL filing
    • Operating cash flow (annual): USD -21.23MSEC XBRL filing
    • R&D expense (annual): USD 1.84MSEC XBRL filing
    • Total operating expenses (annual): USD 24.44MSEC XBRL filing
    • Pre-tax income (annual): USD -18.72MSEC XBRL filing
    • Long-term debt (annual): USD 11.7MSEC XBRL filing
    • Total liabilities (annual): USD 84.21MSEC XBRL filing
    • Capex (annual): USD 144.11KSEC XBRL filing
    • Current assets (annual): USD 15.01MSEC XBRL filing
    • Cash & equivalents (annual): USD 1.37MSEC XBRL filing
    • Revenue (annual): USD 57.19MSEC XBRL filing
    • Gross profit (annual): USD 7.48MSEC XBRL filing
    • Cost of revenue (annual): USD 49.71MSEC XBRL filing
    • Operating income (annual): USD -16.96MSEC XBRL filing
    • Cash & equivalents (annual): USD 1.09MSEC XBRL filing
    Atomic claims from regulatory filings and derived calculations. Provenance shown as source kind only.

    The Thread

    Everything we know, in order
    2026-07-28EVENTUpcomingQ2 2026 earnings (expected) estimated date
    2026-07-20 21:49 UTCEVENTHa Price Listing POM price below 1 ($0.855) — US continued-listing minimum-bid threshold
    2026-05-14FILINGANNUAL REPORT →
    2025-10-09FILINGPROSPECTUS →
    2015-02-16 15:30 UTCEARNINGSAnnual results — FY 2015 Revenue VND 13017.37B · Net VND -1078.38B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-07-26 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage